SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-23-103904
Filing Date
2023-09-26
Accepted
2023-09-26 16:49:07
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2326972d1_sc13da.htm SC 13D/A 53147
2 EXHIBIT 13 tm2326972d1_ex13.htm EX-99.13 117864
3 EXHIBIT 14 tm2326972d1_ex14.htm EX-99.14 30720
4 EXHIBIT 15 tm2326972d1_ex15.htm EX-99.15 38492
  Complete submission text file 0001104659-23-103904.txt   242069
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filed by) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Subject) CIK: 0001820190 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91963 | Film No.: 231280996
SIC: 2836 Biological Products, (No Diagnostic Substances)